Can a heart drug make Omega-3 supplements work better?
NCT ID NCT07304921
First seen Jun 27, 2026 · Last updated Jun 27, 2026
Summary
This completed Phase 1 trial in 48 healthy adults tested whether taking meldonium (a drug) together with omega-3 supplements (EPA and DHA) increases omega-3 levels in the blood more than omega-3 alone. Participants were split into three groups and took different combinations over 8 weeks. The study measured blood levels of omega-3s and related fat metabolites, but did not treat any disease.
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
Active substance
Meldonium and omega-3 (EPA/DHA) supplements
What this could lead to
If it works, this could point toward a way to increase omega-3 levels in the blood more efficiently, which may help in conditions linked to low omega-3.
What could go wrong
This is a very early, small study in healthy volunteers, not patients. It only measures blood levels, not health outcomes. Results may not apply to people with diseases.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for SUPPLEMENTATION are added.
By submitting, you agree to our Terms of use
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Riga Stradins university
Riga, Latvia